{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:35:53Z","timestamp":1791210953320,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1016\/j.neuroscience.2007.03.010","type":"journal-article","created":{"date-parts":[[2007,6,5]],"date-time":"2007-06-05T07:11:59Z","timestamp":1181027519000},"page":"354-372","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Glutamate receptor abnormalities in the YAC128 transgenic mouse model of Huntington\u2019s disease"],"prefix":"10.1016","volume":"147","author":[{"given":"C.L.","family":"Benn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.J.","family":"Slow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.A.","family":"Farrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.R.","family":"Hayden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-H.J.","family":"Cha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2007.03.010_bib1","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1212\/WNL.42.4.733","article-title":"Alternative excitotoxic hypotheses","volume":"42","author":"Albin","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2007.03.010_bib2","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/jnr.10272","article-title":"Striatal neurochemical changes in transgenic models of Huntington\u2019s disease","volume":"68","author":"Ariano","year":"2002","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.neuroscience.2007.03.010_bib3","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/0306-4522(95)00595-1","article-title":"Reduction in enkephalin and substance P messenger RNA in the striatum of early grade Huntington\u2019s disease: a detailed cellular in situ hybridization study","volume":"72","author":"Augood","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2007.03.010_bib4","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/321168a0","article-title":"Replication of the neurochemical characteristics of Huntington\u2019s disease by quinolinic acid","volume":"321","author":"Beal","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2007.03.010_bib5","first-page":"231","article-title":"Neurotransmitter receptor analysis in transgenic mouse models","volume":"277","author":"Benn","year":"2004","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.neuroscience.2007.03.010_bib6","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/jnr.1244","article-title":"NMDA receptor function in mouse models of Huntington disease","volume":"66","author":"Cepeda","year":"2001","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.neuroscience.2007.03.010_bib7","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1098\/rstb.1999.0449","article-title":"Altered neurotransmitter receptor expression in transgenic mouse models of Huntington\u2019s disease","volume":"354","author":"Cha","year":"1999","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.neuroscience.2007.03.010_bib8","doi-asserted-by":"crossref","first-page":"6480","DOI":"10.1073\/pnas.95.11.6480","article-title":"Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene","volume":"95","author":"Cha","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2007.03.010_bib9","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1093\/hmg\/11.17.1939","article-title":"Increased huntingtin protein length reduces the number of polyglutamine-induced gene expression changes in mouse models of Huntington\u2019s disease","volume":"11","author":"Chan","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neuroscience.2007.03.010_bib10","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/0166-2236(90)90111-M","article-title":"Excitotoxic injury of the neostriatum: a model for Huntington\u2019s disease","volume":"13","author":"DiFiglia","year":"1990","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.neuroscience.2007.03.010_bib11","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1046\/j.1471-4159.2003.01744.x","article-title":"Subcellular segregation of distinct heteromeric NMDA glutamate receptors in the striatum","volume":"85","author":"Dunah","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2007.03.010_bib12","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1046\/j.1471-4159.1996.67062335.x","article-title":"Regional and ontogenic expression of the NMDA receptor subunit NR2D protein in rat brain using a subunit-specific antibody","volume":"67","author":"Dunah","year":"1996","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2007.03.010_bib12a","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1523\/JNEUROSCI.4356-06.2007","article-title":"Altered NMDA receptor trafficking in a yeast artificial chromosome transgenic mouse model of Huntington\u2019s disease","volume":"27","author":"Fan","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2007.03.010_bib13","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.pneurobio.2006.11.003","article-title":"N-Methyl-d-aspartate (NMDA) receptor function and excitotoxicity in Huntington\u2019s diseas","volume":"81","author":"Fan","year":"2006","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.neuroscience.2007.03.010_bib14","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1523\/JNEUROSCI.11-12-03877.1991","article-title":"Proliferative and degenerative changes in striatal spiny neurons in Huntington\u2019s disease: a combined study using the section-Golgi method and calbindin D28k immunocytochemistry","volume":"11","author":"Ferrante","year":"1991","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2007.03.010_bib15","doi-asserted-by":"crossref","first-page":"50514","DOI":"10.1074\/jbc.M309348200","article-title":"Enhanced Akt signaling is an early pro-survival response that reflects N-methyl-D-aspartate receptor activation in Huntington\u2019s disease knock-in striatal cells","volume":"278","author":"Gines","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2007.03.010_bib16","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.nbd.2005.08.007","article-title":"Levels of mutant huntingtin influence the phenotypic severity of Huntington disease in YAC128 mouse models","volume":"21","author":"Graham","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2007.03.010_bib17","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.neuron.2005.03.025","article-title":"Pathological cell-cell interactions elicited by a neuropathogenic form of mutant huntingtin contribute to cortical pathogenesis in HD mice","volume":"46","author":"Gu","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2007.03.010_bib18","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0896-6273(00)80764-3","article-title":"A YAC mouse model for Huntington\u2019s disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration","volume":"23","author":"Hodgson","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2007.03.010_bib19","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes","volume":"72","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.neuroscience.2007.03.010_bib20","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1080\/00207450490430453","article-title":"AMPA receptor regulation mechanisms: future target for safer neuroprotective drugs","volume":"114","author":"Jayakar","year":"2004","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.neuroscience.2007.03.010_bib21","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1126\/science.2166337","article-title":"A family of AMPA-selective glutamate receptors","volume":"249","author":"Keinanen","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2007.03.010_bib22","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.brainres.2005.01.029","article-title":"Alterations in dopamine and benzodiazepine receptor binding precede overt neuronal pathology in mice modelling early Huntington disease pathogenesis","volume":"1039","author":"Kennedy","year":"2005","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2007.03.010_bib23","doi-asserted-by":"crossref","first-page":"9112","DOI":"10.1523\/JNEUROSCI.21-23-09112.2001","article-title":"Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington\u2019s disease","volume":"21","author":"Laforet","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2007.03.010_bib24","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.neurobiolaging.2003.04.003","article-title":"Role of NR2B-type NMDA receptors in selective neurodegeneration in Huntington disease","volume":"24","author":"Li","year":"2003","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neuroscience.2007.03.010_bib25","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1152\/jn.00308.2004","article-title":"Enhanced striatal NR2B-containing N-methyl-D-aspartate receptor-mediated synaptic currents in a mouse model of Huntington disease","volume":"92","author":"Li","year":"2004","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.neuroscience.2007.03.010_bib26","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.nbd.2003.08.024","article-title":"Complex alteration of NMDA receptors in transgenic Huntington\u2019s disease mouse brain: analysis of mRNA and protein expression, plasma membrane association, interacting proteins, and phosphorylation","volume":"14","author":"Luthi-Carter","year":"2003","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2007.03.010_bib27","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1093\/hmg\/9.9.1259","article-title":"Decreased expression of striatal signaling genes in a mouse model of Huntington\u2019s disease","volume":"9","author":"Luthi-Carter","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neuroscience.2007.03.010_bib28","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1093\/hmg\/11.17.1927","article-title":"Polyglutamine and transcription: gene expression changes shared by DRPLA and Huntington\u2019s disease mouse models reveal context-independent effects","volume":"11","author":"Luthi-Carter","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neuroscience.2007.03.010_bib29","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.neuroscience.2007.03.010_bib30","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1006\/exnr.1999.7327","article-title":"Decrease in striatal enkephalin mRNA in mouse models of Huntington\u2019s disease","volume":"162","author":"Menalled","year":"2000","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2007.03.010_bib31","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1006\/exnr.2000.7542","article-title":"The role of group I and group II metabotropic glutamate receptors in modulation of striatal NMDA and quinolinic acid toxicity","volume":"167","author":"Orlando","year":"2001","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2007.03.010_bib32","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1212\/WNL.32.12.1391","article-title":"Quantitative autoradiography of neurotransmitter receptors in Huntington disease","volume":"32","author":"Penney","year":"1982","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2007.03.010_bib33","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.nbd.2005.08.001","article-title":"Striatal neuronal apoptosis is preferentially enhanced by NMDA receptor activation in YAC transgenic mouse model of Huntington disease","volume":"21","author":"Shehadeh","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2007.03.010_bib34","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","article-title":"Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease","volume":"12","author":"Slow","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neuroscience.2007.03.010_bib35","doi-asserted-by":"crossref","first-page":"33364","DOI":"10.1074\/jbc.M304240200","article-title":"Expression of polyglutamine-expanded huntingtin induces tyrosine phosphorylation of N-methyl-D-aspartate receptors","volume":"278","author":"Song","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2007.03.010_bib36","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1073\/pnas.0409402102","article-title":"Disturbed Ca2+ signaling and apoptosis of medium spiny neurons in Huntington\u2019s disease","volume":"102","author":"Tang","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2007.03.010_bib37","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/mds.870110209","article-title":"Proton magnetic resonance spectroscopy in Huntington\u2019s disease: evidence in favour of the glutamate excitotoxic theory","volume":"11","author":"Taylor-Robinson","year":"1996","journal-title":"Mov Disord"},{"key":"10.1016\/j.neuroscience.2007.03.010_bib38","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1523\/JNEUROSCI.0590-05.2005","article-title":"Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington\u2019s disease","volume":"25","author":"Van Raamsdonk","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2007.03.010_bib39","series-title":"Huntington\u2019s disease","first-page":"276","article-title":"Striatal neurochemistry of Hungtington\u2019s disease","author":"Yohrling","year":"2002"},{"key":"10.1016\/j.neuroscience.2007.03.010_bib40","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.mcn.2003.11.014","article-title":"Potentiation of NMDA receptor-mediated excitotoxicity linked with intrinsic apoptotic pathway in YAC transgenic mouse model of Huntington\u2019s disease","volume":"25","author":"Zeron","year":"2004","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.neuroscience.2007.03.010_bib41","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0896-6273(02)00615-3","article-title":"Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington\u2019s disease","volume":"33","author":"Zeron","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2007.03.010_bib42","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/hmg\/ddi014","article-title":"Transcriptional dysregulation in striatal projection- and interneurons in a mouse model of Huntington\u2019s disease: neuronal selectivity and potential neuroprotective role of HAP1","volume":"14","author":"Zucker","year":"2005","journal-title":"Hum Mol Genet"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452207003302?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452207003302?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T15:27:34Z","timestamp":1759678054000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452207003302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S0306452207003302"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2007.03.010","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glutamate receptor abnormalities in the YAC128 transgenic mouse model of Huntington\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2007.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 IBRO. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}